Suchergebnisse - "Guglielmetti, Lorenzo"

PubPharm (21)

1

Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Rupasinghe, P. | Ashraf, A. | Barreda, N. | +16

2

Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection : A TBnet and ESGMYC study

enthalten in: The Journal of infection | 2022

von Tunesi, S. | Dû, D. | Gualano, G. | +29

3

Rifapentine access in Europe : growing concerns over key tuberculosis treatment component

enthalten in: The European respiratory journal | 2022

von Guglielmetti, L. | Günther, G. | Leu, C. | +14

CommentIn: Eur Respir J. 2022 Aug 25;60(2):. - PMID 35777762

4

Impact of the revised definition of extensively drug-resistant tuberculosis

enthalten in: The European respiratory journal | 2021

von Veziris, N. | Bonnet, I. | Morel, F. | +11

5

Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis : contribution of murine studies

enthalten in: The European respiratory journal | 2021

von Maitre, T. | Guglielmetti, L. | Veziris, N.

CommentOn: Eur Respir J. 2021 Mar 11;57(3):. - PMID 33154028

6

COVID-19 in Italy : passing through bitter waters

enthalten in: The European respiratory journal | 2020

von Guglielmetti, L. | Chiesi, S.

CommentOn: Eur Respir J. 2020 Jun 11;55(6):. - PMID 32398303

7

WHO 2019 guidelines on drug-resistant tuberculosis treatment : based on evidence or expert opinion?

enthalten in: The European respiratory journal | 2020

von Guglielmetti, L. | Huerga, H. | Khan, U. | +1

CommentOn: Eur Respir J. 2019 Oct 10;54(4):. - PMID 31601719

8

Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis : How Much Better Are They?

enthalten in: American journal of respiratory and critical care medicine | 2018

von Bastard, M. | Guglielmetti, L. | Huerga, H. | +7

9

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe : a Tuberculosis Network European Trialsgroup (TBnet) study

enthalten in: The European respiratory journal | 2018

von Guglielmetti, L. | Tiberi, S. | Burman, M. | +66

10

Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis : a case series from France and Latvia

enthalten in: The European respiratory journal | 2018

von Guglielmetti, L. | Barkane, L. | Le Dû, D. | +7